Dorraji, S. Esmaeil http://orcid.org/0000-0003-1619-6610
Hovd, Aud-Malin K.
Kanapathippillai, Premasany
Bakland, Gunnstein
Eilertsen, Gro Østli
Figenschau, Stine L. http://orcid.org/0000-0002-3714-9998
Fenton, Kristin A. http://orcid.org/0000-0002-8356-2628
Article History
Received: 23 January 2018
Accepted: 9 May 2018
First Online: 18 May 2018
Competing Interests
: Dr. Bakland has been paid 6000 NOK to be part of the advisory board for Novartis, Norway. All other authors have nothing to disclosure. The authors have no non-financial competing interests.